Skip to main content

Coloplast A/S – Transactions in connection with share buy-back programme, week 17

Written by Customer Service on . Posted in Public Companies.

As mentioned in Announcement no. 02/2020 Coloplast is initiating a share buyback programme totalling up to DKK 500 million.
The programme will commence on 24 February 2020 and is expected to end by 24 August 2020.The share buyback programme is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations with the purpose of meeting obligations arising from share options programmes or other allocation of shares to employees or to complete a share capital decrease as set out in Articles 5(2)(a) and 5(2)(c) in MAR.The following transactions have been executed during the period 20 – 24 April 2020:An overview showing the transaction data for the period  20 – 24 April 2020 is enclosed.Henceforth, Coloplast owns 3,288,667 treasury B shares of DKK 1 equal to 1.52% of the company’s total share capital.Kind regards,
Investor Relations
Coloplast A/S
Tel. +45 4911 1800 For further information, please contact
  
Investors and analysts
Ellen Bjurgert
Vice President, Investor Relations
Tel. +45 4911 1800/+45 4911 3376
Email: dkebj@coloplast.comRasmus Sørensen
Sr. Manager, Investor Relations
Tel. +45 4911 1800/ +45 4911 1786
Email: dkraso@coloplast.com
                                                                                       
Press and the media
Lina Danstrup
Sr. Media Relations Manager
Tel. 4911 2607
Email: dklina@coloplast.comAddress
Coloplast A/S
Holtedam 1
DK-3050 Humlebaek
Danmark
CVR NR. 69749917Website
www.coloplast.comThis announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology. We operate globally and employ about 12,000 employees.The Coloplast logo is a registered trademark of Coloplast A/S. © 2020-04.
All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.Attachments2704020_SharebuybackTransaction data_week17

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.